Detalhe da pesquisa
1.
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis.
J Neurol Neurosurg Psychiatry
; 93(9): 986-994, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688629
2.
Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study.
BMC Neurol
; 22(1): 64, 2022 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193507
3.
Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial.
Aesthetic Plast Surg
; 46(3): 1314-1320, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585263
4.
Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies.
J Res Med Sci
; 26: 85, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34760002
5.
A Randomized Controlled Clinical Trial Comparing Clinical and Radiographic Success Rates of MTA and rhBMP2 in Pulpotomy of Primary Teeth.
Front Dent
; 21: 12, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742221
6.
Effect of enteral probiotics on prognostic scores and C-reactive protein levels in critically ill multiple trauma patients: A randomized, double-blind, placebo-controlled clinical trial.
Clin Nutr ESPEN
; 55: 30-37, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202060
7.
Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine.
J Neurol Sci
; 444: 120518, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521195
8.
Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity.
Front Immunol
; 14: 952911, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895555
9.
Neuro-mucormycosis: Lessons from COVID-19-associated cases.
Curr J Neurol
; 22(4): 255-260, 2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425352
10.
Revisiting the antiviral theory to explain interferon-beta's effectiveness for relapsing multiple sclerosis.
Mult Scler Relat Disord
; 67: 104155, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116383
11.
Endoscopic clipping of a complicated esophageal perforation following pneumatic dilation for achalasia: A case study and literature review.
Clin Case Rep
; 10(11): e6620, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447673
12.
Inducing chimeric antigen receptor (CAR) regulatory T cells in-vivo: A novel concept for a potential feasible cure of demyelinating diseases.
Mult Scler Relat Disord
; 57: 103341, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158451
13.
Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model.
PLoS One
; 17(12): e0278488, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477491
14.
Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse.
Hum Vaccin Immunother
; 18(1): 2033540, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239452
15.
Multiple sclerosis in sarcoidosis patients: Two case reports.
Clin Case Rep
; 10(9): e6332, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172327
16.
Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors.
Mult Scler Relat Disord
; 58: 103488, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999375
17.
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
Hum Vaccin Immunother
; 18(1): 2041945, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201963
18.
SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.
Mult Scler Relat Disord
; 57: 103417, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875487
19.
Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient.
Hum Vaccin Immunother
; 17(10): 3481-3483, 2021 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015240
20.
Movement Disorders Associated with COVID-19.
Parkinsons Dis
; 2021: 3227753, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34790346